The Medicines and Healthcare Products Regulatory Agency Trading Fund (Revocation) Order 2022

Statutory Instruments

2022 No. 90

Government Trading Funds

The Medicines and Healthcare Products Regulatory Agency Trading Fund (Revocation) Order 2022

Made

31st January 2022

Laid before the House of Commons

1st February 2022

Coming into force - -

1st April 2022

The Secretary of State, in exercise of the powers conferred by sections 1 and 6(1) of the Government Trading Funds Act 1973(1), with concurrence of the Treasury, makes the following Order:

Citation and commencement

1.  This Order may be cited as the Medicines and Healthcare Products Regulatory Agency Trading Fund (Revocation) Order 2022 and comes into force on 1st April 2022.

Revocation

2.  The instruments specified in the Schedule are revoked to the extent shown in that Schedule.

Signed by authority of the Secretary of State for Health and Social Care

Kamall

Parliamentary Under Secretary of State

Department of Health and Social Care

27th January 2022

Craig Whittaker

Rebecca Harris

Two of the Lord Commissioners

Her Majesty’s Treasury

31st January 2022

Article 2

SCHEDULE Revocations

Instrument	Reference	Extent of Revocation
(1) S.I. 2003/1076, amended by S.I. 2004/994, 2005/2061, 2006/2407, 2012/1916, 2014/432, 2016/549, 2018/378 and 1112.
(2) S.I. 2004/994, to which there are amendments not relevant to this instrument.
(3) S.I. 2006/2407, to which there are amendments not relevant to this instrument.
(4) S.I. 2012/1916, to which there are amendments not relevant to this instrument.
The Medicines Control Agency Trading Fund (Variation) Order 1997	S.I. 1997/805	Entire Order
The Medicines and Healthcare Products Regulatory Agency Trading Fund Order 2003(1)	S.I. 2003/1076	Entire Order
The Good Laboratory Practice (Codification Amendments Etc.) Regulations 2004(2)	S.I. 2004/994	Regulation 3
The Medicines and Healthcare Products Regulatory Agency Trading Fund (Amendment) Order 2005	S.I. 2005/2061	Entire Order
The Veterinary Medicines Regulations 2006(3)	S.I. 2006/2407	Paragraph 12 of Part 2 of Schedule 8
The Human Medicines Regulations 2012(4)	S.I. 2012/1916	Paragraph 78 of Part 5 of Schedule 34
The Medicines and Healthcare Products Regulatory Agency Trading Fund (Appropriation of Additional Assets and Liabilities) Order 2014	S.I. 2014/432	Entire Order
The Medicines and Healthcare Products Regulatory Agency Trading Fund (Amendment) Order 2016	S.I. 2016/549	Entire Order
The Secretaries of State for Health and Social Care and for Housing, Communities and Local Government and Transfer of Functions (Commonhold Land) Order 2018	S.I. 2018/378	Paragraphs 20(e) and 21(h) of Part 2 of Schedule 1
The Medicines and Healthcare Products Regulatory Agency Trading Fund (Amendment) (EU Exit) Order 2018	S.I. 2018/1112	Entire Order

EXPLANATORY NOTE

(This note is not part of the Order)

This Order revokes the Medicines and Healthcare Products Regulatory Agency Trading Fund Order 2003 (‘the 2003 Order’) and all other amending Statutory Instruments or provisions that will become spent when the 2003 Order is revoked, with effect from 1st April 2022. This Order also revokes the Medicines Control Agency Trading Fund (Variation) Order 1997, which became spent when the Medicines Control Agency Trading Order 1993 was revoked and replaced by the 2003 Order.

The trading fund established by the 2003 Order will cease to exist, the operations of MHRA as defined in Schedule 1 to the 2003 Order will cease to be funded by means of a trading fund, and MHRA’s assets and liabilities will no longer be appropriated to a trading fund. MHRA will remain an Executive Agency sponsored by the Department of Health and Social Care.

A full impact assessment has not been produced for this instrument as no, or no significant impact on the private, voluntary or public sector is foreseen.

An Explanatory Memorandum is available alongside this instrument on www.legislation.gov.uk.

(1)

1973 c. 63; sections 1 and 6(1) were amended by the Government Trading Act 1990 (c. 30), sections 1(1) and 2(3)(a) respectively.